您要查找的是不是：
- There are two parts of treatment for AML, called induction therapy and consolidation therapy. 针对急粒的治疗可分为两个阶段：诱导治疗和巩固治疗。
- Randomization was performed before LT. In all patients, tacrolimus was used without induction therapy. 肝移植前就进行了随机抽样。对所有的病人使用免疫抑制药他克莫司，不进行诱导试验。
- The main side effect was myelosuppression.Conclusion:The topotecan-based induction therapy has antileuke... 结论:以拓扑替康为主的联合化疗方案对部分复发难治性急性髓系白血病患者具有确切疗效。
- Induction therapy with MMF is also associated with fewer side effects than induction therapy with CYC. 用于诱导治疗时;霉酚酸酯比环磷酰胺有更少的副作用.
- Method:16 patients with refractory or relapsed AML were treated with topotecan-based induction therapy. 方法:采用以拓扑替康为基础的联合诱导方案治疗难治及复发AML患者16例。
- Oerall, compared with CYC, induction therapy with MMF reduced the risk of infection significantly (RR 0.65, P <0.001). 总之;与环磷酰胺比较;霉酚酸酯用于诱导治疗明显减少了感染的风险(相对风险度0.;65;P<0
- Title:Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. 标题：短期诱导治疗与抗胸腺细胞球蛋白及延迟使用钙调素抑制剂，在原位肝移植。
- BACKGOUND: Thymoglobulin (rATG) has become the agent of choice for induction therapy in high immunological risk kidney transplant recipients. 背景： ATG是免疫高危肾移植受者诱导治疗的选择之一。
- About 45% of the patients received antilymphocyte induction therapy for up to five days and pravastatin or simvastatin unless contraindicated. 大约有45%25的病患，在五天内决定接受抗淋巴细胞引导疗法；
- Compared with intraenous CYC, induction therapy with MMF reduced the incidence of leucopenia significantly (RR 0.66, P = 0.04). 与静脉注射的环磷酰胺相比;用于诱导治疗的霉酚酸酯也明显减少了白细胞减少症的发生.
- All of them had a short induction therapy with anti-thymoglobulin (ATG) and steroids for only 4 days, association with CellCept and tacrolimus. 所有的患者均短期行ATG诱导治疗，激素仅仅使用4天，并联合骁悉和他克莫司。
- Conclusion Basiliximab is safe and effective induction therapy for the sensitized recipient or the second-operation recipient. 结论舒莱是强效、安全的预防急性排斥的免疫抑制剂，在致敏及二次移植受者的免疫治疗中效果满意。
- Objective:To evaluate the antileukemic activity and side effects of topotecan-based induction therapy in patients with refractory and relapsed acute myelogenous leukemia(AML). 目的 :评价以拓扑替康为基础的联合诱导方案治疗难治及复发急性粒细胞白血病 (AML)的疗效及不良反应。
- Objectives To evaluate the efficacy and safety of sequential treatment of newly diagnosed de novo AML patients with IA followed by CAG regimen as induction therapy. 目的观察IA[去甲氧柔红霉素(IDA)+阿糖胞苷(Ara-C)]联合CAG方案[粒细胞集落刺激因子(G-CSF)+Ara-C+阿柔比星(ACLA)]序贯诱导缓解治疗原发初治急性髓系白血病(AML)的疗效和安全性。
- The aim of the study was to analyze the effects of anti-thymocyte globulin (ATG) induction therapy on rejection, renal function, infection, tumor rate, and survival. 该项研究的主要目标是要分析的影响，抗胸腺细胞球蛋白（署理）感应疗法对截留，肾功能，感染，肿瘤率和生存率。
- They either undergo immune tolerance induction therapy, which is extremely expensive and sometimes fails, or are treated with bypassing agents that are also ruinously costly and not always effective. 他们要么接受免疫耐受诱导治疗，这是极其昂贵的，有时还会失败，或者采用旁路治疗，同样也是价格不菲，而且并不总是有效的。
- Short-term ATG induction therapy with delayed administration of calcineurin inhibitors led to a more favorable rejection rate and an improved clinical course in case of a rejection episode. 短期署理诱导治疗迟发行政钙调素抑制剂，导致了更为有利的废品率及改善临床病程的情况下拒绝插曲。
- Case 1 and 2 only reached partial remission after inductive therapy (case 2: relapse at primary sites inductive therapy one month later, but bone marrow: complete remission(CR) ), all of three patients reached CR after ABMT. 尽管例1、例2在诱导治疗后仍为部分缓解(PR) [例2PR缓解期仅30天，原发部位复发，骨髓仍处完全缓解(CR)]，但ABMT治疗后三例均达CR。
- The magnetic signals are sensed by induction coils. 磁信号由感应线圈所检测。
- Self-help is an important element in therapy for the handicapped. 伤残人士在治疗中，自助自立是个重要因素。
